Efficacy and Safety of a New Prolonged Release Formulation...

Efficacy and Safety of a New Prolonged Release Formulation of Alfuzosin 10 mg Once Daily versus Alfuzosin 2.5 mg Thrice Daily and Placebo in Patients with Symptomatic Benign Prostatic Hyperplasia

van Kerrebroeck, P., Jardin, A., Laval, K.U., van Cangh, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
37
Year:
2000
Language:
english
Journal:
European Urology
DOI:
10.1159/000052361
File:
PDF, 135 KB
english, 2000
Conversion to is in progress
Conversion to is failed